These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24835899)

  • 1. A new transcutaneous bone anchored hearing device - the Baha® Attract System: the first experience in Turkey.
    Işeri M; Orhan KS; Kara A; Durgut M; Oztürk M; Topdağ M; Calışkan S
    Kulak Burun Bogaz Ihtis Derg; 2014; 24(2):59-64. PubMed ID: 24835899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pediatric hearing rehabilitation with the Baha® Attract implant system].
    Posta B; Jarabin JA; Perényi Á; Bere Z; Neagos A; Tóth F; Kiss JG; Rovó L
    Orv Hetil; 2017 Feb; 158(8):304-310. PubMed ID: 28218563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of traditional osseointegrated bone-anchored hearing aids to the Baha
    Cedars E; Chan D; Lao A; Hardies L; Meyer A; Rosbe K
    Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():37-42. PubMed ID: 27863639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous Baha Attract system: Long-term outcomes of the French multicenter study.
    Nevoux J; Coudert C; Boulet M; Czajka C; Tavernier L; Daval M; Ayache D; Meller R; Rossetto S; Papon JF; Deveze A
    Clin Otolaryngol; 2018 Dec; 43(6):1553-1559. PubMed ID: 30137669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baha Attract: Our Experience.
    Marfatia H; Shah K; Shelke S; Krishnan K
    Indian J Otolaryngol Head Neck Surg; 2017 Dec; 69(4):544-548. PubMed ID: 29238689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experience in Italy with a new transcutaneous bone conduction implant.
    Marsella P; Scorpecci A; Dalmasso G; Pacifico C
    Acta Otorhinolaryngol Ital; 2015 Feb; 35(1):29-33. PubMed ID: 26015648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional and anatomical comparison between two passive transcutaneous bone conduction implants in children.
    Giannantonio S; Scorpecci A; Pacifico C; Marsella P
    Int J Pediatr Otorhinolaryngol; 2018 May; 108():202-207. PubMed ID: 29605355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant.
    Hol MK; Nelissen RC; Agterberg MJ; Cremers CW; Snik AF
    Otol Neurotol; 2013 Aug; 34(6):1071-5. PubMed ID: 23598702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results with the titanium bone-anchored hearing aid: the U.S. experience.
    Wazen JJ; Caruso M; Tjellstrom A
    Am J Otol; 1998 Nov; 19(6):737-41. PubMed ID: 9831146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate outcomes of a transcutaneous bone conduction hearing device in a paediatric population.
    Dimitriadis PA; Carrick S; Ray J
    Int J Pediatr Otorhinolaryngol; 2017 Mar; 94():59-63. PubMed ID: 28167013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of stability measurements of the Baha® system in children.
    Felton M; Hill-Feltham P; Bruce IA
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):513-6. PubMed ID: 24467920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss.
    Gerdes T; Salcher RB; Schwab B; Lenarz T; Maier H
    Otol Neurotol; 2016 Jul; 37(6):685-91. PubMed ID: 27093021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osseointegrated Auditory Devices-Transcutaneous: Sophono and Baha Attract.
    Kohan D; Ghossaini SN
    Otolaryngol Clin North Am; 2019 Apr; 52(2):253-263. PubMed ID: 30827359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study of Audiologic Outcomes for Two Transcutaneous Bone-Anchored Hearing Devices.
    Powell HR; Rolfe AM; Birman CS
    Otol Neurotol; 2015 Sep; 36(9):1525-31. PubMed ID: 26375976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical, functional and audiological evaluation of new Baha(®) Attract system implantations.
    Gawęcki W; Stieler OM; Balcerowiak A; Komar D; Gibasiewicz R; Karlik M; Szyfter-Harris J; Wróbel M
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3123-30. PubMed ID: 26899281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hearing thresholds obtained with Baha preoperative assessment tools and those obtained with the osseointegrated implant.
    Heywood RL; Patel PM; Jonathan DA
    Ear Nose Throat J; 2011 May; 90(5):E21-7. PubMed ID: 21563076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing Outcomes with Percutaneous and Transcutaneous BAHA® Technology in Conductive and Mixed Hearing Loss.
    Tobia A; Yehudai N; Khnifes R; Shpak T; Roth O; Khayr R; Luntz M
    Otol Neurotol; 2021 Oct; 42(9):1382-1389. PubMed ID: 34528924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Osia® 2 bone conduction hearing implant experience: Nationwide controlled-market release data and single-center outcomes.
    Goldstein MR; Bourn S; Jacob A
    Am J Otolaryngol; 2021; 42(1):102818. PubMed ID: 33166860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bonebridge: preclinical evaluation of a new transcutaneously-activated bone anchored hearing device.
    Huber AM; Sim JH; Xie YZ; Chatzimichalis M; Ullrich O; Röösli C
    Hear Res; 2013 Jul; 301():93-9. PubMed ID: 23467173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center Experience of Over a Hundred Implantations of a Transcutaneous Bone Conduction Device.
    Dimitriadis PA; Hind D; Wright K; Proctor V; Greenwood L; Carrick S; Ray J
    Otol Neurotol; 2017 Oct; 38(9):1301-1307. PubMed ID: 28806309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.